Lars Dyrskjøt
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Lars Dyrskjøt
Jun 22, 2024, 02:24 |
Insight
Guru Sonpavde: ctDNA for Evaluating Minimal Residual Disease in Bladder Cancer
Guru Sonpavde, Phase I and GU Oncology Director at Advent Health Cancer Institute, posted on…
Jun 21, 2024, 11:04 |
Insight
Niklas Klümper: CtDNA will play an important role for tailoring treatment of MIBC
Niklas Klümper, Resident in Urology and Researcher at the Institute for Experimental Oncology at the…
May 14, 2024, 02:29 |
Blog
Shilpa Gupta: Honored to be panel member for this highly productive San Raffaele Hospital retreat with esteemed experts!
Shilpa Gupta, Director GU Oncology at Cleveland Clinic MD, shared a post by Andrea Necchi, Associate Professor…
All:
3
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube